Penumbra, Inc. PEN · SEC Filings

website

4.7K

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical...

Price321.85

Market Cap12.69 B

Float38.3 M

CountryUS

SectorHealthcare

ExchangeNYSE

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Oct 29, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Jul 30, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 6, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 25, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 5, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Jul 29, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Penumbra, Inc. Reports Third Quarter 2026 Financial Results

Oct 29, 2026

8-K

Penumbra, Inc. Reports Second Quarter 2026 Financial Results

Jul 30, 2026

8-K

Penumbra, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jun 22, 2026

8-K

Penumbra, Inc. Stockholders Approve Merger Agreement with Boston Scientific Corporation

May 7, 2026

8-K

Penumbra, Inc. Reports First Quarter 2026 Financial Results

May 6, 2026

8-K

Penumbra Reports Strong Fourth Quarter and Full Year 2025 Financial Results Amid Boston Scientific Acquisition

Feb 25, 2026

Prospectus

TYPE

HEADLINE

FILED AT

425